Lilly Declares Fourth-Quarter 2021 Dividend
The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a fourth-quarter dividend of $0.85 per share on outstanding common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a fourth-quarter dividend of $0.85 per share on outstanding common stock. This dividend is scheduled for payment on December 10, 2021, to shareholders on record as of November 15, 2021. Eli Lilly continues its commitment to improving healthcare through innovative medicines while balancing business growth and shareholder returns.
Positive
- Dividend declared of $0.85 per share, reflecting company confidence.
- Payment date set for December 10, 2021, enhancing shareholder income.
Negative
- None.
Details
News Market Reaction – LLY
The recorded move for LLY in the trading session of this news was +0.46%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
INDIANAPOLIS, Oct. 18, 2021 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2021 of
The dividend is payable on December 10, 2021 to shareholders of record at the close of business on November 15, 2021.
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and www.lilly.com/news. F-LLY
Lilly Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) related to expected dividend payments and reflects Lilly's current beliefs and expectations. However, there are significant risks and uncertainties in pharmaceutical research and development, as well as in business development activities and capital allocation strategies related to the company's business and actual results may differ materially due to various factors. For a further discussion of these and other risks and uncertainties that could cause actual results to differ from Lilly's expectations, please see Lilly's most recent Forms 10-K and 10-Q filed with the U.S. Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.
Refer to:
Jordan Bishop; bishop_jordan@lilly.com; 317-473-5712 (Media)
Kevin Hern; hern_kevin_r@lilly.com; 317-277-1838 (Investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-declares-fourth-quarter-2021-dividend-301402561.html
SOURCE Eli Lilly and Company
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.